Taiyo Holdings
4626.TTSE PRIMEChemicals
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥137.9bn | ¥119.0bn | ¥104.8bn | ¥97.3bn | ¥98.0bn | ¥81.0bn |
| Operating income | ¥32.5bn | ¥22.1bn | ¥18.2bn | ¥16.0bn | ¥18.0bn | ¥13.9bn |
| Ordinary income | ¥32.2bn | ¥21.6bn | ¥17.3bn | ¥15.5bn | ¥18.1bn | ¥13.8bn |
| Net income (owners) | ¥24.0bn | ¥10.8bn | ¥8.7bn | ¥11.4bn | ¥11.8bn | ¥9.5bn |
| Total assets | ¥201.9bn | ¥192.0bn | ¥212.8bn | ¥187.3bn | ¥189.3bn | ¥179.0bn |
| Net assets / equity | ¥115.8bn | ¥103.0bn | ¥100.4bn | ¥92.7bn | ¥85.5bn | ¥76.5bn |
| Operating cash flow | ¥30.7bn | ¥23.7bn | ¥21.2bn | ¥22.7bn | ¥18.3bn | ¥16.3bn |
| EPS (basic) | ¥215.92 | ¥96.59r | ¥77.44r | ¥101.86r | ¥104.56r | ¥167.49 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 196 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 196 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 196 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 196 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 196 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Electronics Materials | ¥95.3bn | ¥29.2bn |
| Medical And Pharmaceutical | ¥36.5bn | ¥5.1bn |
| Other segments | ¥6.1bn | −¥95m |
| Total | ¥131.8bn | ¥34.2bn |
| Total | ¥137.9bn | ¥34.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.